Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
25.80
-1.20 (-4.44%)
At close: May 22, 2026, 4:00 PM EDT
26.50
+0.70 (2.71%)
After-hours: May 22, 2026, 7:57 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $12.76 billion as of May 22, 2026. Its market cap has increased by 362.45% in one year.
Market Cap
12.76B
Enterprise Value
12.76B
1-Year Change
362.45%
Ranking
Category
Stock Price
$25.80
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $12.76B, an increase of 10,522.66%. That is a compound annual growth rate of 161.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 12.76B | 22.86% |
| Dec 31, 2025 | 10.38B | 16,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | 120.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 39.96B |
| Zoetis | 33.42B |
| United Therapeutics | 23.94B |
| Viatris | 19.32B |
| Neurocrine Biosciences | 15.55B |
| Dr. Reddy's Laboratories | 11.40B |
| Elanco Animal Health | 10.41B |
| Lantheus Holdings | 6.26B |